hydroxychloroquine has been researched along with ascorbic acid in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 10 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Deng, B; Guo, M; Liu, H; Tian, S; Zhao, X | 1 |
| Baeten, JM; Barnabas, RV; Bershteyn, A; Brown, E; Celum, C; Chu, H; Miller, RS; Wald, A; Wener, M; Wesche, D | 1 |
| Charles, S; Chen, J; Lin, Y; Liu, XH; Lu, HZ; Lu, SH; Xia, L; Yang, Y; Yang, ZG | 1 |
| Wu, J | 1 |
| Albano, J; Azmaiparashvili, Z; Elbashabsheh, M; Gul, F; Hiedra, R; Lo, KB; Patarroyo Aponte, G; Wright, RM | 1 |
| Bloom, A; Faisal, H; Gaber, AO | 1 |
| Arora, K; De, D; Jindal, AK; Joshi, V; Razmi T, M; Suri, D | 1 |
| Albreem, MA; Alomari, OA; Alsharif, MH; Alsharif, YH; Hossain, MS; Jahid, A; Solyman, AAA; Yahya, K | 1 |
| Mokale, SN; More, SA; Patil, AS; Sakle, NS | 1 |
| Abbasian, L; Dehghan Manshadi, SA; Ghaderkhani, S; Ghiasvand, F; Hasannezhad, M; Jafari, F; JamaliMoghadamSiahkali, S; Koolaji, S; Manafi, N; Meidani, M; Salahshour, F; Salehi, M; Sekhavati Moghadam, E; SeyedAlinaghi, S; Tabarestani, M; Zarezade, B; Zendehdel, A | 1 |
| Yehya, N | 1 |
3 review(s) available for hydroxychloroquine and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Tackle the free radicals damage in COVID-19.
Topics: Acetylcysteine; Animals; Antioxidants; Ascorbic Acid; Azithromycin; Betacoronavirus; Clinical Trials as Topic; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Therapy, Combination; Free Radicals; Glutathione; Humans; Hydroxychloroquine; Mice; Multiple Organ Failure; NF-E2-Related Factor 2; Nitric Oxide; Orthomyxoviridae Infections; Oxidative Stress; Pandemics; Pneumonia, Viral; Reactive Oxygen Species; SARS-CoV-2; Severe Acute Respiratory Syndrome | 2020 |
Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2.
Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; Artificial Intelligence; Ascorbic Acid; Chloroquine; COVID-19; COVID-19 Drug Treatment; COVID-19 Vaccines; Deep Learning; Drug Combinations; Drug Development; Drug Repositioning; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lopinavir; Machine Learning; Ribavirin; Ritonavir; Vitamins | 2020 |
2 trial(s) available for hydroxychloroquine and ascorbic acid
| Article | Year |
|---|---|
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomise
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Ascorbic Acid; Betacoronavirus; Contact Tracing; Coronavirus Infections; COVID-19; Drug Administration Schedule; Female; Humans; Hydroxychloroquine; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Occupational Exposure; Occupational Health; Pandemics; Pneumonia, Viral; Post-Exposure Prophylaxis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; SARS-CoV-2; Time Factors; Treatment Outcome; United States; Virus Shedding; Young Adult | 2020 |
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.
Topics: Antiviral Agents; Ascorbic Acid; Body Temperature; COVID-19 Drug Treatment; Female; Humans; Hydroxychloroquine; Intensive Care Units; Length of Stay; Lopinavir; Male; Middle Aged; Oxygen; Respiratory Distress Syndrome; Ritonavir; Treatment Outcome | 2021 |
7 other study(ies) available for hydroxychloroquine and ascorbic acid
| Article | Year |
|---|---|
Inhibition of autophagy by hydroxychloroquine enhances antioxidant nutrients and delays postharvest fruit senescence of Ziziphus jujuba.
Topics: Antioxidants; Ascorbic Acid; Autophagy; Fruit; Hydrogen Peroxide; Hydroxychloroquine; Lithium Chloride; Nutrients; Phenols; Temperature; Ziziphus | 2019 |
Clinical characteristics of foreign-imported COVID-19 cases in Shanghai, China.
Topics: Adolescent; Adult; Aged; Antibodies, Viral; Ascorbic Acid; Betacoronavirus; China; Coronavirus Infections; COVID-19; Cross-Sectional Studies; Female; Humans; Hydroxychloroquine; Immunologic Factors; Male; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2; Severity of Illness Index; Thymalfasin; Travel; Treatment Outcome | 2020 |
The use of IV vitamin C for patients with COVID-19: a case series.
Topics: Administration, Intravenous; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Ascorbic Acid; COVID-19; COVID-19 Drug Treatment; Drug Therapy, Combination; Feasibility Studies; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Hospital Mortality; Humans; Hydroxychloroquine; Hypoxia; Intubation, Intratracheal; Male; Methylprednisolone; Middle Aged; Respiration, Artificial; Retrospective Studies; Severity of Illness Index; Vitamins | 2020 |
Unexplained Methemoglobinemia in Coronavirus Disease 2019: A Case Report.
Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Humanized; Antioxidants; Ascorbic Acid; Betacoronavirus; Coronavirus Infections; Corynebacterium; Corynebacterium Infections; COVID-19; Cytokine Release Syndrome; Enzyme Inhibitors; Erythrocyte Transfusion; Hematinics; Humans; Hydroxocobalamin; Hydroxychloroquine; Hypoxia; Male; Methemoglobinemia; Methylene Blue; Pandemics; Pneumonia, Bacterial; Pneumonia, Viral; Renal Replacement Therapy; Respiratory Insufficiency; SARS-CoV-2; Shock, Septic | 2020 |
Refractory leg ulcers in prolidase deficiency with antiphospholipid antibody positivity responding to aspirin-hydroxychloroquine-vitamin C combination therapy.
Topics: Antibodies, Antiphospholipid; Ascorbic Acid; Aspirin; Humans; Hydroxychloroquine; Leg Ulcer; Prolidase Deficiency | 2020 |
Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
Topics: Antiviral Agents; Ascorbic Acid; COVID-19; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Drug Therapy, Combination; Humans; Hydroxychloroquine; Lopinavir; Molecular Docking Simulation; Molecular Dynamics Simulation; Protein Binding; Protein Interaction Mapping; Protein Interaction Maps; Ritonavir; SARS-CoV-2; Signal Transduction; Virus Replication | 2021 |
Assessment of the Temporal Trajectory of Clinical Trials for COVID-19 Interventions After Highly Publicized Lay and Medical Attention.
Topics: Adrenal Cortex Hormones; Ascorbic Acid; Clinical Trials as Topic; Communication; COVID-19 Drug Treatment; Decision Making; Humans; Hydroxychloroquine; Judgment; Mass Media; Persuasive Communication; SARS-CoV-2; Sepsis; Social Media | 2021 |